Abstract:It has been shown that NF-κB signaling path is very effective pharmacological target for the treatment of various inflammatory diseases, including bacterial infection-associated acute kidney injury (AKI), which remains a main cause of disability and death in patients. Notably, IκB, the upstream molecular of NF-κB, plays an important role by inhibiting NF-κB activity, and IκB is regulated by cullin-RING E3 ligases (CRLs)-mediated proteasomal degradation. Therefore inhibition of CRLs-mediated neddylation and degradation of IκB would prevent NF-κB-mediated inflammation. MLN4924, a potent neddylation-inhibiting pharmacological agent, has been shown to have significant protective effects against lipopolysaccharide (LPS)-induced pro-inflammatory cytokine production through restriction of the CRL-mediated NF-κB pathway. However, it is still unclear whether MLN4924 plays a protective role through its anti-inflammatory properties in sepsis-induced AKI. In the current research, we explored whether MLN4924 have anti-inflammatory action in LPS-induced AKI mice. Our results show that MLN4924 dramatically decreased the cytotoxicity of LPS and inhibited LPS-induced synthesis and release of pro-inflammatory cytokines, such as TNF-α, IL-6 and IL-1β, in HK2 cells, a renal tubular cell line. In addition, MLN4924 inhibited Nedd8-activating enzymes, which broke the process of cullin proteins neddylation and subsequent CRL target proteins degradation. The MLN4924-induced degradation of CRL attenuated the phosphorylation modification of IκB and IKK-α/β and blocked the nuclear translocation of P50-NF-κB and P65-NF-κB in HK2 cells under LPS stimulation. Finally, our in vivo results show that MLN4924 protected against LPS-induced AKI at relatively low doses. Collectively, these results suggest that pharmacologically blocking neddylation by MLN4924 results in the suppression of pro-inflammatory cytokines generation through the CRL/NF-κB pathway in LPS-stimulated HK2 cells, and attenuated renal inflammation in LPS-induced AKI.

Neddylation pathway regulates the proliferation and survival of macrophages.

Neddylation promotes protein translocation between the cytoplasm and nucleus

Neddylation Pathway Regulates T-Cell Function By Targeting An Adaptor Protein Shc And A Protein Kinase Erk Signaling

Neddylation Plays an Important Role in the Regulation of Murine and Human Dendritic Cell Function.

Neddylation Regulates Macrophages and Implications for Cancer Therapy

Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-κB-CCL2 signaling in lung cancer

Neddylation Alleviates Methicillin-Resistant Staphylococcus aureus Infection by Inducing Macrophage Reactive Oxygen Species Production.

Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways

Targeting Protein Neddylation with an NEDD8-activating Enzyme Inhibitor MLN4924 Induced Apoptosis or Senescence in Human Lymphoma Cells.

E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2

Neddylation Pathway Alleviates Chronic Pancreatitis by Reducing HIF1α-CCL5-dependent Macrophage Infiltration

Neddylation-Independent Activities of MLN4924

Inhibition of Neddylation Plays Protective Role in Lipopolysaccharide-Induced Kidney Damage Through CRL-mediated NF-κB Pathways.

Neddylation Regulation of Immune Responses

Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer

MyD88 NEDDylation Negatively Regulates MyD88-dependent NF-κB Signaling Through Antagonizing Its Ubiquitination.

Abstract P2033: Neddylation Regulates Cardiac Mitochondria Homeostasis

Protein neddylation and its role in health and diseases

Overactivated neddylation pathway as a therapeutic target in lung cancer

Upregulation of Cullin1 neddylation promotes glycolysis and M1 polarization of macrophage via NF-κB p65 pathway in sepsis